Tianjin Pharmaceutical Da Ren Tang Group Corp 주식 주식분석 | 주식가격 | 뉴스 | 600329.SS | CNE000001808 |

날짜	Tianjin Pharmaceutical Da Ren Tang Group Corp 매출	Tianjin Pharmaceutical Da Ren Tang Group Corp EBIT	Tianjin Pharmaceutical Da Ren Tang Group Corp 이익
2026e	10.96 조. undefined	1.65 조. undefined	1.73 조. undefined
2025e	10 조. undefined	1.34 조. undefined	1.46 조. undefined
2024e	9.12 조. undefined	1.08 조. undefined	1.21 조. undefined
2023	8.22 조. undefined	814.79 백만 undefined	986.71 백만 undefined
2022	8.25 조. undefined	681.08 백만 undefined	861.79 백만 undefined
2021	6.91 조. undefined	592.64 백만 undefined	769.14 백만 undefined
2020	6.6 조. undefined	587.5 백만 undefined	661.7 백만 undefined
2019	6.99 조. undefined	536.8 백만 undefined	625.6 백만 undefined
2018	6.36 조. undefined	468 백만 undefined	561.7 백만 undefined
2017	5.69 조. undefined	348.3 백만 undefined	476.1 백만 undefined
2016	6.24 조. undefined	295.8 백만 undefined	423.6 백만 undefined
2015	7.08 조. undefined	393.2 백만 undefined	451.4 백만 undefined
2014	7.09 조. undefined	372.5 백만 undefined	357.8 백만 undefined
2013	6.01 조. undefined	344.1 백만 undefined	351.8 백만 undefined
2012	5.13 조. undefined	268 백만 undefined	441.3 백만 undefined
2011	4.39 조. undefined	271.9 백만 undefined	247.6 백만 undefined
2010	3.47 조. undefined	236.8 백만 undefined	293.3 백만 undefined
2009	2.88 조. undefined	168.4 백만 undefined	257.8 백만 undefined
2008	2.37 조. undefined	92.5 백만 undefined	176.1 백만 undefined
2007	2.26 조. undefined	-185.7 백만 undefined	-70 백만 undefined
2006	2.16 조. undefined	-408.2 백만 undefined	-386.6 백만 undefined
2005	2.52 조. undefined	51.3 백만 undefined	80.8 백만 undefined
2004	2.12 조. undefined	73.1 백만 undefined	64 백만 undefined

	매출	EBIT	이익
2004	2.12 조. CNY	73.1 백만 CNY	64 백만 CNY
2005	2.52 조. CNY	51.3 백만 CNY	80.8 백만 CNY
2006	2.16 조. CNY	-408.2 백만 CNY	-386.6 백만 CNY
2007	2.26 조. CNY	-185.7 백만 CNY	-70 백만 CNY
2008	2.37 조. CNY	92.5 백만 CNY	176.1 백만 CNY
2009	2.88 조. CNY	168.4 백만 CNY	257.8 백만 CNY
2010	3.47 조. CNY	236.8 백만 CNY	293.3 백만 CNY
2011	4.39 조. CNY	271.9 백만 CNY	247.6 백만 CNY
2012	5.13 조. CNY	268 백만 CNY	441.3 백만 CNY
2013	6.01 조. CNY	344.1 백만 CNY	351.8 백만 CNY
2014	7.09 조. CNY	372.5 백만 CNY	357.8 백만 CNY
2015	7.08 조. CNY	393.2 백만 CNY	451.4 백만 CNY
2016	6.24 조. CNY	295.8 백만 CNY	423.6 백만 CNY
2017	5.69 조. CNY	348.3 백만 CNY	476.1 백만 CNY
2018	6.36 조. CNY	468 백만 CNY	561.7 백만 CNY
2019	6.99 조. CNY	536.8 백만 CNY	625.6 백만 CNY
2020	6.6 조. CNY	587.5 백만 CNY	661.7 백만 CNY
2021	6.91 조. CNY	592.64 백만 CNY	769.14 백만 CNY
2022	8.25 조. CNY	681.08 백만 CNY	861.79 백만 CNY
2023	8.22 조. CNY	814.79 백만 CNY	986.71 백만 CNY
2024e	9.12 조. CNY	1.08 조. CNY	1.21 조. CNY
2025e	10 조. CNY	1.34 조. CNY	1.46 조. CNY
2026e	10.96 조. CNY	1.65 조. CNY	1.73 조. CNY

Tianjin Pharmaceutical Da Ren Tang Group Corp 브루토마진	Tianjin Pharmaceutical Da Ren Tang Group Corp 이익 마진	Tianjin Pharmaceutical Da Ren Tang Group Corp EBIT-마진	Tianjin Pharmaceutical Da Ren Tang Group Corp 이익 마진
2026e	43.66 %	15.09 %	15.8 %
2025e	43.66 %	13.36 %	14.58 %
2024e	43.66 %	11.84 %	13.24 %
2023	43.66 %	9.91 %	12 %
2022	39.49 %	8.26 %	10.45 %
2021	39.76 %	8.58 %	11.13 %
2020	39.07 %	8.9 %	10.02 %
2019	41.76 %	7.68 %	8.94 %
2018	41.2 %	7.36 %	8.83 %
2017	38.68 %	6.12 %	8.37 %
2016	32.27 %	4.74 %	6.79 %
2015	29.48 %	5.55 %	6.38 %
2014	30.27 %	5.26 %	5.05 %
2013	31.86 %	5.73 %	5.85 %
2012	34.12 %	5.22 %	8.6 %
2011	34.85 %	6.19 %	5.64 %
2010	37.77 %	6.82 %	8.44 %
2009	37.54 %	5.85 %	8.95 %
2008	36.93 %	3.91 %	7.45 %
2007	34.28 %	-8.22 %	-3.1 %
2006	35.01 %	-18.86 %	-17.86 %
2005	42.58 %	2.04 %	3.21 %
2004	45.13 %	3.45 %	3.02 %

	브루토마진	EBIT-마진	이익 마진
2004	45.13 %	3.45 %	3.02 %
2005	42.58 %	2.04 %	3.21 %
2006	35.01 %	-18.86 %	-17.86 %
2007	34.28 %	-8.22 %	-3.1 %
2008	36.93 %	3.91 %	7.45 %
2009	37.54 %	5.85 %	8.95 %
2010	37.77 %	6.82 %	8.44 %
2011	34.85 %	6.19 %	5.64 %
2012	34.12 %	5.22 %	8.6 %
2013	31.86 %	5.73 %	5.85 %
2014	30.27 %	5.26 %	5.05 %
2015	29.48 %	5.55 %	6.38 %
2016	32.27 %	4.74 %	6.79 %
2017	38.68 %	6.12 %	8.37 %
2018	41.2 %	7.36 %	8.83 %
2019	41.76 %	7.68 %	8.94 %
2020	39.07 %	8.9 %	10.02 %
2021	39.76 %	8.58 %	11.13 %
2022	39.49 %	8.26 %	10.45 %
2023	43.66 %	9.91 %	12 %
2024e	43.66 %	11.84 %	13.24 %
2025e	43.66 %	13.36 %	14.58 %
2026e	43.66 %	15.09 %	15.8 %

날짜	Tianjin Pharmaceutical Da Ren Tang Group Corp 주당 매출	Tianjin Pharmaceutical Da Ren Tang Group Corp EBIT 당 주식	Tianjin Pharmaceutical Da Ren Tang Group Corp 주당 이익
2026e	14.25 undefined	0 undefined	2.25 undefined
2025e	13.01 undefined	0 undefined	1.9 undefined
2024e	11.86 undefined	0 undefined	1.57 undefined
2023	10.69 undefined	1.06 undefined	1.28 undefined
2022	10.63 undefined	0.88 undefined	1.11 undefined
2021	8.98 undefined	0.77 undefined	1 undefined
2020	8.59 undefined	0.76 undefined	0.86 undefined
2019	9.1 undefined	0.7 undefined	0.81 undefined
2018	8.26 undefined	0.61 undefined	0.73 undefined
2017	7.4 undefined	0.45 undefined	0.62 undefined
2016	8.12 undefined	0.38 undefined	0.55 undefined
2015	9.21 undefined	0.51 undefined	0.59 undefined
2014	9.59 undefined	0.5 undefined	0.48 undefined
2013	8.13 undefined	0.47 undefined	0.48 undefined
2012	6.94 undefined	0.36 undefined	0.6 undefined
2011	5.94 undefined	0.37 undefined	0.33 undefined
2010	4.7 undefined	0.32 undefined	0.4 undefined
2009	3.9 undefined	0.23 undefined	0.35 undefined
2008	3.2 undefined	0.13 undefined	0.24 undefined
2007	3.05 undefined	-0.25 undefined	-0.09 undefined
2006	2.93 undefined	-0.55 undefined	-0.52 undefined
2005	3.4 undefined	0.07 undefined	0.11 undefined
2004	2.86 undefined	0.1 undefined	0.09 undefined

	주당 매출	EBIT 당 주식	주당 이익
2004	2.86 CNY	0.1 CNY	0.09 CNY
2005	3.4 CNY	0.07 CNY	0.11 CNY
2006	2.93 CNY	-0.55 CNY	-0.52 CNY
2007	3.05 CNY	-0.25 CNY	-0.09 CNY
2008	3.2 CNY	0.13 CNY	0.24 CNY
2009	3.9 CNY	0.23 CNY	0.35 CNY
2010	4.7 CNY	0.32 CNY	0.4 CNY
2011	5.94 CNY	0.37 CNY	0.33 CNY
2012	6.94 CNY	0.36 CNY	0.6 CNY
2013	8.13 CNY	0.47 CNY	0.48 CNY
2014	9.59 CNY	0.5 CNY	0.48 CNY
2015	9.21 CNY	0.51 CNY	0.59 CNY
2016	8.12 CNY	0.38 CNY	0.55 CNY
2017	7.4 CNY	0.45 CNY	0.62 CNY
2018	8.26 CNY	0.61 CNY	0.73 CNY
2019	9.1 CNY	0.7 CNY	0.81 CNY
2020	8.59 CNY	0.76 CNY	0.86 CNY
2021	8.98 CNY	0.77 CNY	1 CNY
2022	10.63 CNY	0.88 CNY	1.11 CNY
2023	10.69 CNY	1.06 CNY	1.28 CNY
2024e	11.86 CNY	0 CNY	1.57 CNY
2025e	13.01 CNY	0 CNY	1.9 CNY
2026e	14.25 CNY	0 CNY	2.25 CNY

	주식 수량
2004	739.3 백만 Aktien
2005	739.3 백만 Aktien
2006	739.3 백만 Aktien
2007	739.3 백만 Aktien
2008	739.3 백만 Aktien
2009	739.3 백만 Aktien
2010	739.3 백만 Aktien
2011	739.3 백만 Aktien
2012	739.3 백만 Aktien
2013	739.3 백만 Aktien
2014	739.3 백만 Aktien
2015	768.9 백만 Aktien
2016	768.9 백만 Aktien
2017	768.9 백만 Aktien
2018	769.4 백만 Aktien
2019	768.9 백만 Aktien
2020	768.9 백만 Aktien
2021	769.14 백만 Aktien
2022	776.39 백만 Aktien
2023	768.87 백만 Aktien
2024e	768.87 백만 Aktien
2025e	768.87 백만 Aktien
2026e	768.87 백만 Aktien

날짜	Tianjin Pharmaceutical Da Ren Tang Group Corp 배당금
2026e	1.21 undefined
2025e	1.21 undefined
2024e	1.21 undefined
2023	1.12 undefined
2022	0.5 undefined
2021	0.3 undefined
2020	0.3 undefined
2019	0.22 undefined
2018	0.2 undefined
2017	0.15 undefined
2016	0.25 undefined
2015	0.15 undefined
2014	0.05 undefined
2013	0.1 undefined
2012	0.2 undefined
2011	0.2 undefined
2006	0.08 undefined
2005	0.08 undefined
2004	0.08 undefined

	배당금	배당금 (추정)
2004	0.08 CNY	0 CNY
2005	0.08 CNY	0 CNY
2006	0.08 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0 CNY	0 CNY
2011	0.2 CNY	0 CNY
2012	0.2 CNY	0 CNY
2013	0.1 CNY	0 CNY
2014	0.05 CNY	0 CNY
2015	0.15 CNY	0 CNY
2016	0.25 CNY	0 CNY
2017	0.15 CNY	0 CNY
2018	0.2 CNY	0 CNY
2019	0.22 CNY	0 CNY
2020	0.3 CNY	0 CNY
2021	0.3 CNY	0 CNY
2022	0.5 CNY	0 CNY
2023	1.12 CNY	0 CNY
2024e	0 CNY	1.21 CNY
2025e	0 CNY	1.21 CNY
2026e	0 CNY	1.21 CNY

날짜	Tianjin Pharmaceutical Da Ren Tang Group Corp 배당률
2026e	37.84 %
2025e	39.64 %
2024e	37.23 %
2023	36.64 %
2022	45.05 %
2021	30 %
2020	34.88 %
2019	27.16 %
2018	27.4 %
2017	24.19 %
2016	45.45 %
2015	25.42 %
2014	10.42 %
2013	20.83 %
2012	33.33 %
2011	60.61 %
2010	36.64 %
2009	36.64 %
2008	36.64 %
2007	36.64 %
2006	-14.42 %
2005	68.18 %
2004	83.33 %

	배당률
2004	83.33 %
2005	68.18 %
2006	-14.42 %
2007	36.64 %
2008	36.64 %
2009	36.64 %
2010	36.64 %
2011	60.61 %
2012	33.33 %
2013	20.83 %
2014	10.42 %
2015	25.42 %
2016	45.45 %
2017	24.19 %
2018	27.4 %
2019	27.16 %
2020	34.88 %
2021	30 %
2022	45.05 %
2023	36.64 %
2024e	37.23 %
2025e	39.64 %
2026e	37.84 %

EPS-예상치	EPS-실제	보고 분기
0.22	0.13 (-41.49 %)	2014 Q4
0.18	0.08 (-56 %)	2014 Q3
0.15	0.13 (-14.19 %)	2014 Q2
0.21	0.16 (-24.56 %)	2013 Q4
0.14	0.06 (-57.57 %)	2013 Q3
0.13	0.1 (-20.82 %)	2013 Q2

%-지분	이름	주식	변경
42.38 %	Tianjin Pharmaceutical Holdings Ltd.	325,855,528	0
1.09 %	Fullgoal Fund Management Co., Ltd.	8,392,119	-340,800
0.70 %	Zhong Ou Asset Management Co., Ltd.	5,348,982	-8,489,300
0.61 %	GF Fund Management Co., Ltd.	4,711,501	-1,989,900
0.57 %	Chen (Shihui)	4,418,118	4,418,118
0.54 %	China Universal Asset Management Co., Ltd.	4,124,015	-422,094
0.31 %	Hotland Innovation Asset Management Co., Ltd.	2,413,803	-230,080
0.29 %	E Fund Management Co. Ltd.	2,252,050	-2,748,720
0.29 %	China Southern Asset Management Co. Ltd.	2,228,492	117,800
0.27 %	ICBC Credit Suisse Asset Management Co. Ltd.	2,107,589	-243,100
0.23 %	Cinda Fund Management Co., Ltd.	1,805,256	-2,020,600
0.22 %	China Asset Management Co., Ltd.	1,722,109	53,900
0.21 %	Bosera Asset Management Co., Ltd.	1,589,300	-30,200
0.20 %	Penghua Fund Management Co., Ltd.	1,510,738	310,800
0.19 %	ZhongRong Fund Mgmt Co., Ltd	1,434,538	-638,862
0.17 %	The Vanguard Group, Inc.	1,311,297	0
0.16 %	JPMorgan Asset Management (China) Company Limited.	1,254,249	1,214,649
0.15 %	China Merchants Fund Management Co. Ltd.	1,153,883	-160,300
0.14 %	Western Leadbank Fund Management Co., Ltd.	1,040,100	1,040,100
0.12 %	CCB Principal Asset Management Co., Ltd.	913,135	103,700
0.11 %	AXA-SPDB Investment Managers Co., Ltd.	813,400	695,400
0.10 %	Harvest Fund Management Co., Ltd.	803,209	-741,615
0.09 %	Guotai Junan Securities Assets Management Co., Ltd.	692,400	692,400
0.09 %	Broad Asset Management Co., Ltd	686,600	686,600
0.08 %	Great Wall Fund Management Co., Ltd.	628,300	-21,700
0.08 %	Tianhong Asset Management Co., Ltd.	579,300	14,300
0.07 %	CITIC Prudential Fund Management Co., Ltd.	560,672	500,000
0.07 %	Zhong Hai Fund Management Co., Ltd.	548,127	548,127
0.06 %	Changsheng Fund Management Co., Ltd.	498,100	-25,400
0.06 %	Morgan Stanley Investment Management (China) Company Limited.	480,200	30,300
0.06 %	Founder Fubon Fund Management Co., Ltd.	460,677	0
0.06 %	Norges Bank Investment Management (NBIM)	458,108	458,108
0.05 %	First-Trust Fund Management Co., Ltd.	388,188	-157,228
0.05 %	Hongde Fund Management Co., Ltd.	349,200	-696,900
0.04 %	Bank of Communications Schroder Fund Management Co., Ltd.	297,773	-5,088,456
0.04 %	Baoying Fund Management Co., Ltd.	273,100	-499,300
0.03 %	Dacheng Fund Management Co., Ltd.	260,201	256,600
0.03 %	Value Partners Ltd.	246,572	-41,400
0.03 %	Maxwealth Fund Management Co., Ltd.	220,000	218,100
0.03 %	Chang Xin Asset Management Co., Ltd.	212,000	-269,200
0.03 %	PengYang Asset Management Co., Ltd	207,000	207,000
0.03 %	Huashang Fund Management Co., Ltd.	200,000	200,000
0.03 %	Dimensional Fund Advisors, L.P.	198,372	-200
0.03 %	Yinhua Fund Management Co., Ltd.	198,031	125,400
0.03 %	Everbright PGIM Fund Management Co., Ltd.	197,000	-179,100
0.02 %	CICC Fund Management Co Ltd.	170,700	-6,500
0.02 %	INVESCO Great Wall Fund Management Co. Ltd.	167,255	-3,200
0.02 %	Wanjia Asset Management Co., Ltd.	167,159	-2,781,983
0.02 %	BOC International (China) Ltd.	142,800	200
0.02 %	Hwabao WP Fund Management Co., Ltd.	116,000	90,000
0.01 %	Huatai-PineBridge Fund Management Co., Ltd.	112,780	-214,603
0.01 %	TongTai Asset Management Co., Ltd.	103,700	103,700
0.01 %	Focusbridge Investments Limited	98,000	98,000
0.01 %	Orient Securities Asset Management Company Limited	95,600	95,600
0.01 %	Handelsbanken Kapitalförvaltning AB	95,500	0
0.01 %	UBS SDIC Fund Management Co., Ltd.	92,800	15,100
0.01 %	BOSC Asset Management Co., Ltd.	87,700	-33,600
0.01 %	Ping An Fund Management Company Limited	77,400	-6,200
0.01 %	ABC-CA Fund Management Co., Ltd.	68,100	-2,897,300
0.01 %	Xinghua Fund Management Co., Ltd.	48,200	48,200
0.01 %	Soochow Asset Management Co., Ltd.	47,200	-34,900
0.01 %	China Fund Management Co., Ltd.	41,600	-28,600
0.01 %	Guotai Asset Management Co., Ltd.	38,700	-445,509
0.00 %	BlackRock Investment Management (UK) Ltd.	38,200	0
0.00 %	SWS MU Fund Management Co., Ltd.	33,300	33,300
0.00 %	JX Asset Management Co., Ltd.	32,078	-84,800
0.00 %	Topsperity Fund Management Co., Ltd.	31,900	22,300
0.00 %	Taikang Asset Management Co., Ltd.	28,100	25,000
0.00 %	CITIC Securities Co., Ltd. (Asset Management)	27,600	27,600
0.00 %	Donghai Funds Management Co., Ltd.	26,800	26,800
0.00 %	Manulife Fund Management Co., Ltd.	25,700	1,000
0.00 %	Sealand Securities Co., Ltd.	23,849	14,349
0.00 %	Zhou (Hong)	23,800	-46,200
0.00 %	Wang (Xin)	23,800	-46,200
0.00 %	Niu (Sheng Fang)	23,800	-46,200
0.00 %	Horizon Asset Management Co., Ltd.	20,700	-4,100
0.00 %	AVIC Fund Management Co., Ltd.	18,700	12,600
0.00 %	Caitong Fund Management Co., Ltd.	18,100	-31,200
0.00 %	China Life AMP Asset Management Co., Ltd	17,200	-300
0.00 %	China Everbright Assets Management, Ltd.	17,000	17,000
0.00 %	HuaAn Fund Management Co., Ltd.	16,900	-1,328,600
0.00 %	Goldstate Capital Fund Management Co., Ltd.	15,000	15,000
0.00 %	CPIC Fund Management Co., Ltd.	14,500	14,500
0.00 %	DBX Advisors LLC.	13,900	13,900
0.00 %	Nykredit Bank AS	13,400	0
0.00 %	Dimensional Fund Advisors, Ltd.	13,000	-6,600
0.00 %	Minsheng Royal Fund Management Company Ltd.	12,200	4,800
0.00 %	Neuberger Berman Fund Management (China) Co., Ltd.	11,739	11,739
0.00 %	Truvalue Asset Management Co., Ltd.	10,500	-1,186,838
0.00 %	Jiao (Yan)	10,200	-19,800
0.00 %	Shanghai Haitong Securities Asset Management Ltd.	10,100	-3,800
0.00 %	Tibet Eastmoney Fund Management Co., Ltd.	9,500	-100
0.00 %	Xingyin Fund Management Co., Ltd.	9,300	9,300
0.00 %	Orient Fund Management Co. Ltd.	9,000	-70,000
0.00 %	Harvest Global Investments Limited	7,162	0
0.00 %	Jyah Asset Management.Co.,LTD	7,000	5,500
0.00 %	Golden Trust Sinopac Fund Management Co., Ltd.	6,500	6,500
0.00 %	Essence Fund Management Co., Ltd.	6,100	-9,400
0.00 %	Everbright Securities Asset Management Co., Ltd.	5,800	-5,900
0.00 %	Northeast Ronghui Securities Asset Management Co., Ltd.	4,900	4,900

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Citigroup	공급업체고객	0,69	-0,04	0,80	0,66	0,43	0,57
GlaxoSmithKline	공급업체고객	0,36	-0,43	-0,80	-0,59	-0,42	0,31
Standard Chartered	공급업체고객	0,33	0,71	-0,68	-0,32	-0,34	0,26
Tianjin Lisheng Pharm A	공급업체고객	0,12	0,91	0,83	0,28	0,17	-0,40
Tianjin Development Hldgs	공급업체고객	0,05	-0,58	0,72	0,34	0,18	0,54
DBS Group Holdings	공급업체고객	-0,53	-0,72	0,53	0,47	0,02	0,75
ABN AMRO DR	공급업체고객	-0,70	-0,75	-0,21	0,60	0,30	0,78

What values and corporate philosophy does Tianjin Pharmaceutical Da Ren Tang Group Corp represent?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd represents values of innovation, integrity, and quality in the pharmaceutical industry. With a strong corporate philosophy focused on delivering cutting-edge healthcare solutions, the company strives to provide safe and effective pharmaceutical products to improve people's well-being. Tianjin Zhongxin Pharmaceutical Group Corp Ltd's commitment to research and development, along with its dedication to meeting international standards, has positioned the company as a leader in the global pharmaceutical market. Through its emphasis on quality control, continuous improvement, and customer satisfaction, Tianjin Zhongxin Pharmaceutical Group Corp Ltd ensures the delivery of reliable and trustworthy healthcare solutions.

In which countries and regions is Tianjin Pharmaceutical Da Ren Tang Group Corp primarily present?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd is primarily present in China.

What significant milestones has the company Tianjin Pharmaceutical Da Ren Tang Group Corp achieved?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd has achieved several significant milestones. It has successfully expanded its product portfolio, notably in the areas of cardiovascular, respiratory, and anti-infective medicines. The company has also secured numerous international certifications, including Good Manufacturing Practice (GMP) certification, ensuring the highest quality standards. Tianjin Zhongxin Pharmaceutical Group Corp Ltd has made remarkable strides in research and development as well, with several innovative drugs being registered and commercialized. Furthermore, the company has established a robust global presence by entering into strategic partnerships and expanding its market reach. These achievements consolidate Tianjin Zhongxin Pharmaceutical Group Corp Ltd's position as a leading player in the pharmaceutical industry.

What is the history and background of the company Tianjin Pharmaceutical Da Ren Tang Group Corp?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd, a leading pharmaceutical company, has a rich history and background. Established in [year], the company has been dedicated to providing high-quality healthcare products and services to global markets. With a focus on research and development, manufacturing, and marketing, Tianjin Zhongxin has emerged as a trusted name in the pharmaceutical industry. Its commitment to innovation, quality, and customer satisfaction has enabled it to expand its presence both domestically and internationally. Being one of the prominent players in the pharmaceutical market, Tianjin Zhongxin Pharmaceutical Group Corp Ltd continuously strives for excellence through its diverse product portfolio and relentless pursuit of breakthrough solutions in healthcare.

Who are the main competitors of Tianjin Pharmaceutical Da Ren Tang Group Corp in the market?

The main competitors of Tianjin Zhongxin Pharmaceutical Group Corp Ltd in the market include other leading pharmaceutical companies such as Shanghai Pharmaceuticals Holding Co., Ltd., Sinopharm Group Co., Ltd., Fosun Pharma, and Jiangsu Hengrui Medicine Co., Ltd.

In which industries is Tianjin Pharmaceutical Da Ren Tang Group Corp primarily active?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd primarily operates in the pharmaceutical industry.

What is the business model of Tianjin Pharmaceutical Da Ren Tang Group Corp?

The business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd focuses on the development, production, and sales of pharmaceutical products. As one of the leading pharmaceutical companies in China, Tianjin Zhongxin Pharmaceutical Group Corp Ltd aims to provide high-quality and affordable medications to improve the health and well-being of individuals. With a diverse product portfolio ranging from traditional Chinese medicine to modern pharmaceuticals, the company emphasizes research and innovation to meet the growing healthcare needs of its customers. By adhering to strict quality standards and maintaining a strong distribution network, Tianjin Zhongxin Pharmaceutical Group Corp Ltd ensures the availability and accessibility of its products nationwide.

Tianjin Pharmaceutical Da Ren Tang Group Corp 2024의 P/E 비율은 얼마입니까?

Tianjin Pharmaceutical Da Ren Tang Group Corp의 P/E 비율은 19.99입니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp 2024의 KUV는 얼마입니까?

Tianjin Pharmaceutical Da Ren Tang Group Corp의 P/S 비율은 2.65입니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp의 AlleAktien 품질 점수는 얼마인가요?

Tianjin Pharmaceutical Da Ren Tang Group Corp에 대한 AlleAktien 품질 점수는 7/10입니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp 2024의 매출은 얼마인가요?

예상되는 Tianjin Pharmaceutical Da Ren Tang Group Corp 매출은 9.12 조. CNY입니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp 2024의 이익은 얼마인가요?

예상되는 Tianjin Pharmaceutical Da Ren Tang Group Corp 이익은 1.21 조. CNY입니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp은 무엇을 하나요?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd is a Chinese company specialized in the production and sale of pharmaceutical products, health and dietary supplements, and medical devices. Its business model is based on a comprehensive range of products and services that allow it to meet the needs of customers in different markets. The company is divided into several divisions, including the pharmaceutical products division, the dietary supplements division, and the medical devices division. Each of these divisions offers unique products and services tailored to specific needs and requirements. In the field of pharmaceutical products, Tianjin Zhongxin Pharmaceutical Group Corp Ltd manufactures a variety of drugs used to treat various diseases and conditions. This includes antibiotics, anti-inflammatory drugs, cancer medications, as well as treatments for cardiovascular diseases and diabetes. The company also has a research and development department that continuously works on the development of new drugs. The dietary supplements division offers a wide range of products aimed at improving health and well-being. These include vitamins, minerals, enzymes, and herbal extracts. The company adheres to strict standards in the production of its products and uses only high-quality and natural ingredients. The medical devices division of Tianjin Zhongxin Pharmaceutical Group Corp Ltd specializes in the production of medical devices such as blood glucose monitors and blood pressure monitors. These devices are of high quality and comply with all applicable standards and regulations. The business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd also includes collaborations with other companies and organizations around the world. The company has partnerships with a variety of domestic and international companies to expand its product range and strengthen its global presence. Overall, the business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd is focused on the development, production, and sale of high-quality pharmaceutical products, dietary supplements, and medical devices. Its divisions offer a wide range of products and services tailored to the needs of customers in different markets. Through its global presence and collaborations with other companies and organizations worldwide, the company ensures continuous expansion and future success.

Tianjin Pharmaceutical Da Ren Tang Group Corp 배당금은 얼마입니까?

Tianjin Pharmaceutical Da Ren Tang Group Corp은(는) 연간 번의 배당을 통해 0.5 CNY의 배당금을 지급합니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp이 얼마나 자주 배당을 지급하나요?

Tianjin Pharmaceutical Da Ren Tang Group Corp의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp ISIN이 무엇입니까?

Tianjin Pharmaceutical Da Ren Tang Group Corp의 ISIN은 CNE000001808입니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp 티커는 무엇인가요?

Tianjin Pharmaceutical Da Ren Tang Group Corp의 티커는 600329.SS입니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Tianjin Pharmaceutical Da Ren Tang Group Corp은(는) 1.12 CNY 의 배당금을 지급했습니다. 이는 약 3.57 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Tianjin Pharmaceutical Da Ren Tang Group Corp은(는) 1.21 CNY의 배당금을 지급할 것으로 예상됩니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp의 배당 수익률은 얼마입니까?

Tianjin Pharmaceutical Da Ren Tang Group Corp의 현재 배당 수익률은 3.57 %입니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp의 배당금은 언제 지급되나요?

Tianjin Pharmaceutical Da Ren Tang Group Corp은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp의 배당금은 얼마나 안전한가요?

Tianjin Pharmaceutical Da Ren Tang Group Corp은(는) 지난 16년 동안 매년 배당금을 지급했습니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp의 배당금은 얼마입니까?

향후 12개월 동안 1.21 CNY의 배당금이 예상됩니다. 이는 배당수익률 3.85 %에 해당합니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp이(가) 속해 있는 섹터는 어디인가요?

Tianjin Pharmaceutical Da Ren Tang Group Corp은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Tianjin Pharmaceutical Da Ren Tang Group Corp kaufen, um die vorherige Dividende zu erhalten?

Tianjin Pharmaceutical Da Ren Tang Group Corp의 마지막 배당금을 1.12 CNY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp의 2023년도 배당금은 얼마였습니까?

2023년에 Tianjin Pharmaceutical Da Ren Tang Group Corp는 0.5 CNY를 배당금으로 지급했습니다.

Tianjin Pharmaceutical Da Ren Tang Group Corp는 어떤 화폐로 배당금을 지급하나요?

Tianjin Pharmaceutical Da Ren Tang Group Corp의 배당금은 CNY에 지급됩니다.

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	769	861
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	123	114
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10	-56
-84	-198	-353	-350	-462	-536	-667	-682	-493	-471	-629	-611	-737	-884	-1,370	-1,547	-1,679	-1,664	-1,816	-2,084	-2,305	-2,068	-2,316	-2,255
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-186	-191
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-59	-93	-146	-162	-180	-203	-178	-198	-197	-260	-254	-328	-374	-424	-495	-511	-505	-487	-514	-554	-598	-523	-496	-526
69	-14	157	187	76	10	261	-28	20	113	83	139	173	20	213	286	360	417	-4	350	495	671	852	677
-54	-79	-134	-180	-589	-252	-149	-63	-53	-38	-86	-68	-43	-41	-72	-70	-92	-118	-114	-175	-205	-189	-156	-107
74	22	-67	-114	-654	-109	-61	120	253	97	22	11	33	22	-166	102	-428	86	197	382	-100	73	-311	-12
128	101	66	65	-65	143	88	184	307	135	108	80	76	63	-93	172	-335	204	311	557	104	262	-154	95
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-22	-1	-244	51	564	114	64	-51	-145	-162	-49	-80	5	63	185	-273	-367	-19	-42	-10	-222	0	0	179
14	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-83	-85	54	-22	505	-4	-67	-187	-234	-246	-86	-120	-197	-75	266	-491	273	-339	-161	-252	-370	-237	-244	-236
-75	-83	369	22	28	9	5	0	0	0	19	4	1	0	239	-99	784	-114	8	-77	25	-4	-12	-29
0	0	-69	-96	-87	-128	-136	-136	-89	-84	-56	-45	-204	-138	-157	-118	-143	-205	-127	-164	-173	-232	-232	-387
0.27	0.2	0.8	0.75	0.65	0.65	1.24	0.76	0.75	0.81	0.99	1.11	1.3	1.3	2.39	2.24	2.75	2.73	2.36	3.47	3.42	3.77	3.96	3.89
14.8	-93.9	23.7	7.2	-512.6	-241.8	112.1	-91.8	-33.6	75.4	-3.3	70.2	130.9	-20.4	141	216.7	268	299.6	-118.4	174.3	289.9	482.2	695.45	569.34
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Scope 1 - 직접 방출	—
스코프 2 - 구매한 에너지로부터의 간접적인 배출	—
Scope 3 - 가치 창출 체인 내의 간접 배출	—
총 CO₂ 배출량	—
CO₂ 감소 전략	✅
석탄 에너지	❌
원자력	❌
동물 실험	✅
펠츠 & 레더	—
살충제	—
팜 오일	—
담배	❌
유전자 변형 생물체	❌
기후 개념	—
지속 가능한 임업	—
재활용 규정	❌
환경 친화적인 포장	❌
위험물질	❌
연료 소비량과 효율성	❌
물 사용량 및 효율성	✅

여성 직원 비율	—
관리 직위에서의 여성 비율	—
아시아 직원 비율	—
아시아 경영진 비율	—
히스패닉/라티노 직원 비율	—
히스패닉/라티노 관리 부문 지분	—
흑인 직원 비율	—
블랙 매니지먼트 지분	—
흰색 종업원의 비율	—
화이트 매니지먼트 지분	—
성인 콘텐츠	❌
알코올	❌
무기	—
총기	❌
도박	❌
군사 계약	❌
인권 개념	❌
개인정보 보호 정책	—
작업 및 건강 보호	✅
카톨릭	✅

환경 보고	✅
이해관계자 참여	❌
콜백 정책	❌
카르텔법	❌

Tianjin Pharmaceutical Da Ren Tang Group Corp 티커	Tianjin Pharmaceutical Da Ren Tang Group Corp FIGI
600329:CH	BBG000CWRRB4
600329:CG	BBG000CWRRX0
600329:C1	BBG00709HMS7

1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0.29	0.41	0.82	1.52	1.84	2.06	2.12	2.52	2.16	2.26	2.37	2.88	3.47	4.39	5.13	6.01	7.09	7.08	6.24	5.69	6.36	6.99	6.6	6.91	8.25	8.22	9.12	10	10.96
-	44.06	99.51	85.04	20.91	12.23	2.47	19.01	-14.02	4.34	4.74	21.78	20.59	26.43	16.81	17.18	17.90	-0.08	-11.84	-8.86	11.76	9.99	-5.58	4.60	19.43	-0.33	10.92	9.66	9.58
49.65	50.49	42.58	37.48	36.81	41.72	45.11	42.55	34.98	34.28	36.91	37.53	37.75	34.84	34.12	31.85	30.27	29.48	32.27	38.67	41.19	41.76	39.07	39.76	39.48	43.66	-	-	-
0.14	0.21	0.35	0.57	0.68	0.86	0.95	1.07	0.76	0.77	0.87	1.08	1.31	1.53	1.75	1.91	2.15	2.09	2.01	2.2	2.62	2.92	2.58	2.75	3.26	3.59	0	0	0
0.03	0.04	0.04	0.06	0.06	0.07	0.07	0.05	-0.41	-0.19	0.09	0.17	0.24	0.27	0.27	0.34	0.37	0.39	0.3	0.35	0.47	0.54	0.59	0.59	0.68	0.81	1.08	1.34	1.65
11.19	9.71	4.50	3.81	3.15	3.54	3.45	2.03	-18.85	-8.19	3.89	5.83	6.80	6.17	5.23	5.72	5.25	5.55	4.73	6.12	7.36	7.66	8.89	8.57	8.26	9.90	11.84	13.36	15.09
0.15	0.11	0.09	0.06	0.09	0.09	0.06	0.08	-0.39	-0.07	0.18	0.26	0.29	0.25	0.44	0.35	0.36	0.45	0.42	0.48	0.56	0.63	0.66	0.77	0.86	0.99	1.21	1.46	1.73
-	-22.45	-24.56	-26.74	34.92	1.18	-25.58	25.00	-582.50	-81.87	-351.43	46.02	14.01	-15.70	78.54	-20.41	1.71	26.33	-6.21	12.53	17.86	11.41	5.76	16.34	11.96	14.52	22.41	20.80	18.72
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
659.3	659.3	659.3	739.3	739.3	739.3	739.3	739.3	739.3	739.3	739.3	739.3	739.3	739.3	739.3	739.3	739.3	768.9	768.9	768.9	769.4	768.9	768.9	769.14	776.39	768.87	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

한 눈에 저평가된 주식을 인식하세요

가격

가격

티커600329.SS

ISINCNE000001808

Tianjin Pharmaceutical Da Ren Tang Group Corp 주식 매출, EBIT, 이익 CNE000001808 ·

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Tianjin Pharmaceutical Da Ren Tang Group Corp 매출, 이익 및 EBIT 역사

Tianjin Pharmaceutical Da Ren Tang Group Corp 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Tianjin Pharmaceutical Da Ren Tang Group Corp 주식 마진 CNE000001808 ·

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Tianjin Pharmaceutical Da Ren Tang Group Corp 마진 역사

Tianjin Pharmaceutical Da Ren Tang Group Corp 주식 매출, EBIT, 주당 순이익 CNE000001808 ·

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Tianjin Pharmaceutical Da Ren Tang Group Corp 매출, 이익 및 EBIT 주당 역사

Tianjin Pharmaceutical Da Ren Tang Group Corp 주식 및 주식 분석

Tianjin Pharmaceutical Da Ren Tang Group Corp 역사적인 P/E, EBIT 및 P/S에 따른 평가

Tianjin Pharmaceutical Da Ren Tang Group Corp 주식 수량 CNE000001808 ·

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Tianjin Pharmaceutical Da Ren Tang Group Corp 주식 분할

Tianjin Pharmaceutical Da Ren Tang Group Corp 주식 배당금 CNE000001808 ·

배당금

배당금에 대한 개요

해석 및 사용

투자 전략

Tianjin Pharmaceutical Da Ren Tang Group Corp 배당금 내역

Tianjin Pharmaceutical Da Ren Tang Group Corp 주식 배당률 CNE000001808 ·

배당비율

연간 배당비율이란 무엇인가요?

데이터 해석 방법

투자에 대한 데이터 사용

Tianjin Pharmaceutical Da Ren Tang Group Corp 배당금지급률 역사

Tianjin Pharmaceutical Da Ren Tang Group Corp 수익 예상

Tianjin Pharmaceutical Da Ren Tang Group Corp 수익 놀라움

Eulerpool ESG Scorecard© Tianjin Pharmaceutical Da Ren Tang Group Corp 주식을 위해

Eulerpool World ESG Rating (EESG©)

47/ 100

🌱 Environment

👫 Social

🏛️ Governance

환경

소셜 (사회적)

지배구조 (기업 경영)

Tianjin Pharmaceutical Da Ren Tang Group Corp 주식 주주 구조

Tianjin Pharmaceutical Da Ren Tang Group Corp 공급망

Tianjin Pharmaceutical Da Ren Tang Group Corp 주식에 대한 자주 묻는 질문

What values and corporate philosophy does Tianjin Pharmaceutical Da Ren Tang Group Corp represent?

In which countries and regions is Tianjin Pharmaceutical Da Ren Tang Group Corp primarily present?

티커
600329.SS

ISIN
CNE000001808